Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$3.63 - $4.03 $31,374 - $34,831
-8,643 Reduced 45.35%
10,414 $38,000
Q3 2022

Nov 10, 2022

SELL
$3.48 - $4.51 $155,507 - $201,533
-44,686 Reduced 70.1%
19,057 $71,000
Q2 2022

Aug 12, 2022

SELL
$3.82 - $4.89 $24,066 - $30,806
-6,300 Reduced 8.99%
63,743 $277,000
Q1 2022

May 13, 2022

SELL
$4.74 - $6.68 $42,660 - $60,120
-9,000 Reduced 11.39%
70,043 $333,000
Q2 2021

Aug 12, 2021

BUY
$6.9 - $9.59 $309,120 - $429,632
44,800 Added 130.83%
79,043 $581,000
Q1 2021

May 13, 2021

SELL
$8.58 - $10.21 $27,087 - $32,232
-3,157 Reduced 8.44%
34,243 $320,000
Q4 2020

Feb 12, 2021

BUY
$9.32 - $13.4 $151,916 - $218,420
16,300 Added 77.25%
37,400 $349,000
Q3 2020

Nov 13, 2020

BUY
$12.07 - $15.31 $254,677 - $323,041
21,100 New
21,100 $255,000

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $275M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track Jeremy Grantham's Portfolio

Track Jeremy Grantham Portfolio

Follow Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.